AYTU BIOPHARMA, INC — Director's Dealing 2016

Nov 4, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AYTU BIOSCIENCE, INC (AYTU)
CIK: 0001385818
Period of Report: 2016-11-02

Reporting Person: Disbrow Joshua R. (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-02	Common Stock	P	166666	$1.50	Acquired	442694	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-11-02	Warrant to Purchase Common Stock	$1.86	P	166666	Acquired	2021-11-02	Common Stock (166666)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant to Purchase Common Stock	$6.00	2021-05-06	Common Stock (20834)	20834	Direct
Employee Stock Option Grant	$3.23	2025-11-11	Common Stock (50000)	50000	Direct
Employee Stock Option Grant	$3.23	2026-07-07	Common Stock (60000)	60000	Direct

Footnotes

F1: The shares of stock and warrants were purchased at a purchase price per unit of $1.50.

F2: Of these shares, 190,000 are restricted shares that vest on July 7, 2026, subject to earlier vesting in certain situations.

F3: 33.3% vest on November 11, 2016, 33.3% vest on November 11, 2017 and 33.3% vest on November 11, 2018, subject to the Grantee's continued service as an employee on such dates.

F4: 33.3% vests on the one year, two year and three year anniversary of the date of grant, subject to the Grantee's continued service as an employee on such dates.